ANGIOTENSIN-II RECEPTOR SUBTYPES AND PHOSPHOINOSITIDE HYDROLYSIS IN RAT ADRENAL-MEDULLA

被引:48
作者
ISRAEL, A [1 ]
STROMBERG, C [1 ]
TSUTSUMI, K [1 ]
GARRIDO, MD [1 ]
TORRES, M [1 ]
SAAVEDRA, JM [1 ]
机构
[1] NIMH,CLIN SCI LAB,PHARMACOL SECT,BETHESDA,MD 20892
关键词
PHOSPHOINOSITIDE TURNOVER; CGMP; RAT ADRENAL MEDULLA; ANGIOTENSIN II RECEPTOR SUBTYPES; LOSARTAN;
D O I
10.1016/0361-9230(95)02011-F
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Angiotensin II (ANG) receptor subtypes were characterized by quantitative autoradiography after incubation with the ANG agonist [I-125]Sar(1)-ANG in rat adrenal medulla. ANG receptors are highly localized in adrenal medulla. Specific binding was displaced by 4% and by 95% with the AT(1) receptor blocker losartan and the AT(2) receptor competitor CGP 42112A, respectively. Analysis of competition curves indicated relative binding potencies for the AT(2) population of CGP 42112A>PD 123319> PD 123177. ANG stimulated inositol phosphate formation in a dose-dependent manner in rat adrenal medulla. Losartan at concentrations of 10(-9) to 10(-5) M antagonized the effect of ANG, whereas PD 123177 or PD 123319 had no antagonistic action, However, at a higher concentration (10(-5) M) PD 123177 or PD 123319 potentiated the effect of ANG on InsP(1)-accumulation. In the presence of PO 123319 (10(-5) M) ANG dose-response curve was shifted to the left with no change in the maximal effect. This affect was blocked by the addition of losartan (10(-5) M). On the contrary, the addition of CGP 42112A (10(-6) M) inhibited ANG-induced increase in InsP(1)-accumulation. On the other hand, ANG and CGP 42112A reduced basal cyclic GMP formation, this effect was partially reverted by sodium orthovanadate, a phosphotyrosine phosphatase inhibitor, Our results further demonstrate the presence of two ANG receptor subtypes in adrenal medulla: ANG binding to AT(1) receptor stimulates inositol phospholipid metabolism, whereas ANG binding to AT(2) receptors decreases both inositol phosphate production and cGMP formation.
引用
收藏
页码:441 / 446
页数:6
相关论文
共 46 条
[11]  
CHANG RSL, 1990, MOL PHARMACOL, V29, P347
[12]   [H-3] DUP-753, A HIGHLY POTENT AND SPECIFIC RADIOLIGAND FOR THE ANGIOTENSIN-II-1 RECEPTOR SUBTYPE [J].
CHIU, AT ;
MCCALL, DE ;
ALDRICH, PE ;
TIMMERMANS, PBMWM .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1990, 172 (03) :1195-1202
[13]   DISCRIMINATION OF ANGIOTENSIN-II RECEPTOR SUBTYPES BY DITHIOTHREITOL [J].
CHIU, AT ;
MCCALL, DE ;
NGUYEN, TT ;
CARINI, DJ ;
DUNCIA, JV ;
HERBLIN, WF ;
UYEDA, RT ;
WONG, PC ;
WEXLER, RR ;
JOHNSON, AL ;
TIMMERMANS, PBMWM .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 170 (1-2) :117-118
[14]   BIOCHEMICAL-CHARACTERIZATION OF 2 ANGIOTENSIN-II RECEPTOR SUBTYPES IN THE RAT [J].
DEGASPARO, M ;
WHITEBREAD, S ;
MELE, M ;
MOTANI, AS ;
WHITCOMBE, PJ ;
RAMJOUE, HP ;
KAMBER, B .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1990, 16 :S31-S35
[15]   ANGIOTENSIN-II RECEPTORS AND ALDOSTERONE PRODUCTION IN RAT ADRENAL GLOMERULOSA CELLS [J].
DOUGLAS, J ;
AGUILERA, G ;
KONDO, T ;
CATT, K .
ENDOCRINOLOGY, 1978, 102 (03) :685-696
[16]   ANGIOTENSIN-II RECEPTORS OF HUMAN AND PRIMATE ADRENAL FASCICULATA AND GLOMERULOSA - CORRELATIONS OF BINDING AND STEROIDOGENESIS [J].
DOUGLAS, JG ;
BROWN, GP ;
WHITE, C .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1984, 33 (08) :685-688
[17]  
DUDLEY DT, 1991, MOL PHARMACOL, V40, P360
[18]  
DUNN LA, 1983, J BIOL CHEM, V258, P4989
[19]   MECHANISMS OF ACTION OF CALCIUM-MOBILIZING AGONISTS - SOME VARIATIONS ON A YOUNG THEME [J].
EXTON, JH .
FASEB JOURNAL, 1988, 2 (11) :2670-2676
[20]   RENIN AND ANGIOTENSIN - THE COMPLETE SYSTEM WITHIN THE NEURO-BLASTOMA X GLIOMA CELL [J].
FISHMAN, MC ;
ZIMMERMAN, EA ;
SLATER, EE .
SCIENCE, 1981, 214 (4523) :921-923